These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28095628)

  • 1. Sensitization from ketotifen fumarate in eye drops presenting as chronic conjunctivitis.
    Smets K; Werbrouck J; Goossens A; Gilissen L
    Contact Dermatitis; 2017 Feb; 76(2):124-126. PubMed ID: 28095628
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact dermatitis in response to ketotifen fumarate contained in eye drops.
    Romita P; Stingeni L; Barlusconi C; Hansel K; Foti C
    Contact Dermatitis; 2020 Jul; 83(1):35-37. PubMed ID: 32064627
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis.
    Kidd M; McKenzie SH; Steven I; Cooper C; Lanz R;
    Br J Ophthalmol; 2003 Oct; 87(10):1206-11. PubMed ID: 14507747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ketotifen fumarate (Zaditen) eye drops in the treatment of seasonal allergic conjunctivitis].
    Haicl P; Cerná H
    Cesk Slov Oftalmol; 2004 Sep; 60(5):362-7. PubMed ID: 15566225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population.
    Abelson MB; Ferzola NJ; McWhirter CL; Crampton HJ
    Pediatr Allergy Immunol; 2004 Dec; 15(6):551-7. PubMed ID: 15610370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular tolerability and safety of ketotifen fumarate ophthalmic solution.
    Abelson MB; Chapin MJ; Kapik BM; Shams NB
    Adv Ther; 2002; 19(4):161-9. PubMed ID: 12431041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of preservative-free ketotifen fumarate and preserved olopatadine hydrochloride eye drops in the treatment of moderate to severe seasonal allergic conjunctivitis.
    Mortemousque B; Bourcier T; Khairallah M; Messaoud R; Brignole-Baudouin F; Renault D; Rebika H; Brémond-Gignac D;
    J Fr Ophtalmol; 2014 Jan; 37(1):1-8. PubMed ID: 24388379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Subtle Historical Clue Unlocks a Contact Puzzle.
    DeBord L; Enos T; Cruz P
    Dermatitis; 2019; 30(1):77. PubMed ID: 30570572
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparing the effects of ketotifen fumarate eye drops and ketotifen oral pills on symptom severity and quality of life in patients with allergic rhinitis: a double-blind randomized clinical trial.
    Akhavan A; Karimi-Sari H; Khosravi MH; Arefzadeh E; Yavarahmadi M
    Int Forum Allergy Rhinol; 2015 May; 5(5):386-91. PubMed ID: 25678217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice.
    Shii D; Oda T; Shinomiya K; Katsuta O; Nakamura M
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):321-8. PubMed ID: 19650707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model.
    Abelson MB; Chapin MJ; Kapik BM; Shams NB
    Arch Ophthalmol; 2003 May; 121(5):626-30. PubMed ID: 12742839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drugs for allergic conjunctivitis.
    Med Lett Drugs Ther; 2000 May; 42(1077):39-40. PubMed ID: 10825920
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergic conjunctivitis from eyedrops.
    Blanco R; Quirce S; Pedraza L; Díez-Gómez ML
    Allergy; 1997 Jun; 52(6):686-7. PubMed ID: 9226074
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and Tolerability of Ketotifen in the Treatment Of Seasonal Allergic Conjunctivitis: Comparison between Ketotifen 0.025% and 0.05% Eye Drops.
    Leonardi A; Capobianco D; Benedetti N; Capobianco A; Cavarzeran F; Scalora T; Modugno R; Feuerman OM
    Ocul Immunol Inflamm; 2019; 27(8):1352-1356. PubMed ID: 30303746
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM; Tekelioglu Y; Turk A; Akyol N
    Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis.
    Lai DS; Lue KH; Hsieh JC; Lin KL; Lee HS
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):589-98. PubMed ID: 12487225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
    Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS
    Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference.
    Leonardi A; Zafirakis P
    Curr Med Res Opin; 2004 Aug; 20(8):1167-73. PubMed ID: 15324519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OTC Products: Alaway and Zaditor.
    Brahmbhatt Y; Lee KW
    J Am Pharm Assoc (2003); 2007; 47(6):e27-8. PubMed ID: 18032127
    [No Abstract]   [Full Text] [Related]  

  • 20. [Agranulocytosis induced by ketotifen].
    González Silva M; Botero Flores L
    Sangre (Barc); 1997 Jun; 42(3):260-1. PubMed ID: 9381282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.